EXTRACAPSULAR EXTENSION OF AXILLARY LYMPH NODE METASTASES IN HER2 RECEPTOR POSITIVE AND NEGATIVE BREAST CANCERS: PROGNOSTIC VALUE

被引：0
|
作者：
Maksimovic, S. [1 ]
机构：
[1] Gen Hosp Sveti Vracevi Bijeljina, Bijeljina, Bosnia & Herceg
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [41] HER2/neu overexpression does not predict axillary lymph node metastases in invasive lobular carcinoma of the breast
    Tan, LC
    Kleer, CG
    LABORATORY INVESTIGATION, 2001, 81 (01) : 38A - 38A
  • [42] Eradication of Axillary Lymph Node Metastases Occurs in 74% of Patients Receiving Neoadjuvant Chemotherapy with Concurrent Trastuzumab for HER2 Positive Breast Cancer
    Dominici, L. S.
    Gonzalez, Negron V. M.
    Buzdar, A. U.
    Lucci, A.
    Mittendorf, E. A.
    Pusztai, L.
    Krishnamurthy, S.
    Le-Petross, H. T.
    Babiera, G.
    Bedrosian, I
    Meric-Bernstam, F.
    Hunt, K. K.
    Valero, V.
    Kuerer, H. M.
    CANCER RESEARCH, 2009, 69 (24) : 566S - 566S
  • [43] Prognostic value of tumour markers in patients with axillary node negative breast cancers.
    Wang, YS
    Liu, Q
    Hao, XP
    Jiang, WG
    Mansel, RE
    BRITISH JOURNAL OF CANCER, 1998, 78 : 25 - 25
  • [44] The prognosis of HER2/neu expression in axillary lymph node-negative breast cancer patients.
    Di, GH
    Li, HC
    Hou, YF
    Lu, JS
    Wu, J
    Liu, GY
    Shen, ZZ
    Shao, ZM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 873S - 873S
  • [45] Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
    Rakha, Emad A.
    Agarwal, Devika
    Green, Andrew R.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Ball, Graham
    Alaskandarany, Mohammed A.
    HISTOPATHOLOGY, 2017, 70 (04) : 622 - 631
  • [46] Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?
    Monica Maria Yepes
    Ada Pat Romilly
    Fernando Collado-Mesa
    Jose Miguel Net
    Richard Kiszonas
    Kristopher L. Arheart
    Daniel Young
    Stefan Glück
    Breast Cancer Research and Treatment, 2014, 148 : 117 - 123
  • [47] Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?
    Yepes, Monica Maria
    Romilly, Ada Pat
    Collado-Mesa, Fernando
    Net, Jose Miguel
    Kiszonas, Richard
    Arheart, Kristopher L.
    Young, Daniel
    Glueck, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (01) : 117 - 123
  • [48] EGFR as a prognostic marker in women with hormone receptor and HER2/neu negative breast cancers
    Lu, J.
    Ylagan, L. R.
    Watson, M. A.
    Trinkaus, K.
    Fleming, T. P.
    Aft, R. L.
    MODERN PATHOLOGY, 2008, 21 : 44A - 44A
  • [49] EGFR as a prognostic marker in women with hormone receptor and HER2/neu negative breast cancers
    Lu, J.
    Ylagan, L. R.
    Watson, M. A.
    Trinkaus, K.
    Fleming, T. P.
    Aft, R. L.
    LABORATORY INVESTIGATION, 2008, 88 : 44A - 44A
  • [50] The Prognostic Value of Lymph Node Metastasis Number, Size and Extracapsular Extension in Distal and Perihilar Bile Duct Cancers
    Lee, Yangkyu
    Park, Hyunjin
    Lee, Kyoungbun
    Ahn, Soomin
    Kim, Haeryoung
    MODERN PATHOLOGY, 2019, 32
12345